Glenmark Therapeutics Inc., USA is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)

GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiaries Gene Biotechnology Enterprises Ltd

Moleculin Biotech, Inc. a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses

HanAll Biopharma Co., Ltd. a global biopharmaceutical company committed to discovering and developing innovative medicines for patients

CStone Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission

Bioheng Therapeutics US LLC, a clinical-stage biotech company dedicated to developing innovative universal CAR-T cell therapies

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL

Following its 16 July 2024 announcement, CordenPharma is pleased to share significant progress on its growth initiatives

Kyverna Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases

Myosin Therapeutics, Inc. a biotechnology company developing novel therapies for cancer and neurological disorders